Temasek, Yunfeng lead funding for genomics firm

May 03, 2017

SHANGHAI • Alibaba chief Jack Ma’s private equity firm Yunfeng Capital and Temasek Holdings have led a US$75 million (S$104.75 million) fund-raising round for genomics company WuXi NextCODE, the firm said in a statement yesterday, underlining a race for medical data in China.

WuXi NextCODE, a contract genomics organisation with offices in Shanghai, Iceland and the United States, said it would use the funds to commercialise its products for China, and boost its capabilities in artificial intelligence and deep learning.  Read more

Source: The Straits Times